We found out what patients really want

While algorithms can undoubtedly recall far more medical data than a human, they still can’t hold a candle to understanding the nuances of communication. Even so, more than half of Twitter users who responded would prefer a computer determine their rare disease.

But AI isn’t everything. Apparently usability trumps trustworthiness for patients' health information preferences, and people with chronic diseases are finding solace in selfies and memes. 


Company Amt Investors Source
Valencell $11M Gulf Islamic Investments, TDF Ventures, WSJ Joshua Fund MedCity News
Oncology Analytics $7.5M BlueCross Blue Shield Venture Partners, Sandbox Industries MedCity News
Eight $6M Y Combinator, Yunqui Partners, Azure Capital, Cota Capital, Comcast Ventures, others TechCrunch
Palo Alto Health Sciences $3.5M Undisclosed SEC
Constant Therapy $2M Golden Seeds, Kapor Capital, Launchpad Venture Group, Pond Capital, others MedCity News

Get the full roundup of digital health funding deals since 2011. Subscribe to our funding database.